Cidara Therapeutics, Inc. (CDTX): Price and Financial Metrics
Cidara Therapeutics, Inc. (CDTX)
Today's Latest Price: $3.19 USD
Updated Oct 22 4:00pm
Add CDTX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CDTX Stock Summary
- Of note is the ratio of Cidara Therapeutics Inc's sales and general administrative expense to its total operating expenses; merely 12.16% of US stocks have a lower such ratio.
- The ratio of debt to operating expenses for Cidara Therapeutics Inc is higher than it is for about merely 14.87% of US stocks.
- Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for CDTX comes in at -37.07% -- higher than that of only 11.57% of stocks in our set.
- If you're looking for stocks that are quantitatively similar to Cidara Therapeutics Inc, a group of peers worth examining would be SYBX, PIRS, NXTC, KALV, and XENE.
- CDTX's SEC filings can be seen here. And to visit Cidara Therapeutics Inc's official web site, go to www.cidara.com.
CDTX Stock Price Chart Interactive Chart >
CDTX Price/Volume Stats
| Current price | $3.19 | 52-week high | $4.45 |
| Prev. close | $2.98 | 52-week low | $1.30 |
| Day low | $2.96 | Volume | 136,500 |
| Day high | $3.27 | Avg. volume | 287,162 |
| 50-day MA | $3.20 | Dividend yield | N/A |
| 200-day MA | $3.23 | Market Cap | 137.04M |
Cidara Therapeutics, Inc. (CDTX) Company Bio
Cidara Therapeutics, Inc. focuses on the discovery, development, and commercialization of novel anti-infectives for the treatment of diseases. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in June 2014. The company was founded in 2012 and is based in San Diego, California.
Loading social stream, please wait...